VEGFA and glioblastoma: In order to further quantify the more invasive growth pattern of GBM treated with B20 anti-VEGF antibody in contrast to tumors in untreated controls with a more destructive growth pattern and compression of the surrounding brain tissue, we used automated image analysis to quantitate the amount of myelin within the tumors as a measure of preserved brain structure.